Antares Pharma, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Antares Pharma with three other
companies in this sector in the United States:
sales of $55.38 million
Infusystems Holdings Inc.
of which 69%
was Trauma and Deformity).
Antares Pharma reported sales of $63.55 million
December of 2018.
increase of 16.6%
versus 2017, when the company's sales were $54.52 million.
Sales at Antares Pharma have increased during each of the previous five years
(and since 2013, sales have increased a total of 208%).